Smoking Cessation for Patients With Cancer: State of the Evidence
Journal of the National Comprehensive Cancer Network · 2025-05 · 23 (Supplement)
DOI: 10.6004/jnccn.2025.5009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-05. Verfasst von James M. Davis und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Although it is generally well-known that smoking poses numerous risks to physical health and well-being, it carries additional risks for patients with cancer. Therefore, smoking cessation is of particular concern among this patient population. At the NCCN 2025 Annual Conference, a panel convened to discuss the current evidence surrounding smoking-associated risks for patients with cancer, the benefits of smoking cessation specific to them, and evidence-based approaches to improve rates of smoking cessation.
Zitieren
APA
Davis, J. M., Edmondson, D., Reid, M. E., & Bierut, L. J. (2025). Smoking Cessation for Patients With Cancer: State of the Evidence. Journal of the National Comprehensive Cancer Network, 23(Supplement). https://doi.org/10.6004/jnccn.2025.5009
Vancouver
Davis JM, Edmondson D, Reid ME, Bierut LJ. Smoking Cessation for Patients With Cancer: State of the Evidence. Journal of the National Comprehensive Cancer Network. 2025;23(Supplement). doi:10.6004/jnccn.2025.5009
BibTeX
@article{Davis2025,
author = {Davis, James M. and Edmondson, Donna and Reid, Mary E. and Bierut, Laura Jean},
title = {Smoking Cessation for Patients With Cancer: State of the Evidence},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {Supplement},
doi = {10.6004/jnccn.2025.5009}
}
EUVIMED